A detailed history of Ridgewood Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ridgewood Investments LLC holds 427 shares of LLY stock, worth $336,557. This represents 0.19% of its overall portfolio holdings.

Number of Shares
427
Previous 415 2.89%
Holding current value
$336,557
Previous $375,000 0.8%
% of portfolio
0.19%
Previous 0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$772.14 - $960.02 $9,265 - $11,520
12 Added 2.89%
427 $378,000
Q4 2023

Jan 11, 2024

SELL
$525.19 - $619.13 $4,201 - $4,953
-8 Reduced 1.89%
415 $241,000
Q1 2023

Apr 25, 2023

BUY
$310.63 - $364.82 $131,396 - $154,318
423 New
423 $145,000
Q4 2017

Jan 12, 2018

SELL
$81.94 - $87.89 $220,500 - $236,511
-2,691 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$77.07 - $85.54 $207,395 - $230,188
2,691
2,691 $230,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ridgewood Investments LLC Portfolio

Follow Ridgewood Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgewood Investments LLC with notifications on news.